<bill session="117" type="h" number="5950" updated="2023-03-08T19:58:48Z">
  <state datetime="2021-11-12">REFERRED</state>
  <status>
    <introduced datetime="2021-11-12"/>
  </status>
  <introduced datetime="2021-11-12"/>
  <titles>
    <title type="display">Improving Patient Access to Care and Treatment Act</title>
    <title type="short" as="introduced">Improving Patient Access to Care and Treatment Act</title>
    <title type="official" as="introduced">To amend the Controlled Substances Act to increase the number of days before which certain controlled substances for maintenance or detoxification treatment must be administered, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="D000631"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2021-12-14"/>
    <cosponsor bioguide_id="F000466" joined="2021-11-12"/>
    <cosponsor bioguide_id="K000386" joined="2021-11-26"/>
    <cosponsor bioguide_id="S001205" joined="2021-11-12"/>
    <cosponsor bioguide_id="S000929" joined="2021-11-12"/>
    <cosponsor bioguide_id="T000469" joined="2021-12-02"/>
  </cosponsors>
  <actions>
    <action datetime="2021-11-12">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-11-12" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-11-12">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-11-15">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2022-11-01">
      <text>Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSJU08" name="House Judiciary" subcommittee="Crime and Federal Government Surveillance" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="7666" relation="unknown"/>
    <bill session="117" type="s" number="3257" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
  </subjects>
  <amendments/>
  <summary date="2023-01-11T20:01:08Z" status="Introduced in House">Improving Patient Access to Care and Treatment Act

This bill increases the number of days&#8212;from 14 to 60&#8212;within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.</summary>
</bill>
